Phase II trial of oral topotecan and intravenous carboplatin with G-CSF (filgrastim) support in previously untreated patients with extensive stage small cell lung cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carboplatin; Filgrastim; Topotecan
- Indications Small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 07 Dec 2016 Biomarkers information updated
- 18 Sep 2008 Actual end date added (1 Aug 2008) as reported by ClinicalTrials.gov.
- 30 Sep 2005 New trial record.